Lessons from a successful investment

Guest Speaker: Arthur Roach

How Parkinson’s UK Made a Seed and Series A Equity Investments Worth £4.5m in a UK Biotech Start-up
Starts: May 2, 2024 1:00 pm

|

Ends: 2:00 pm

Guest Speaker: Arthur Roach

|

Director of the Parkinson’s Virtual Biotech

Event Location: Online

00
Days
00
Hours
00
Minutes
00
Seconds

Introducing the Parkinson's Virtual Biotech, a visionary endeavour initiated by Parkinson’s UK in 2017 and now flourishing as an international collaboration with the Parkinson’s Foundation. Their joint mission is to expedite the journey towards a cure by fostering collaboration over competition.

For more insights into this partnership, we invite you to visit the Parkinson's Foundation website.

Their strategy focuses on pinpointing projects with the utmost potential to revolutionise the lives of individuals affected by Parkinson’s. We engage in dynamic partnerships to expedite the development and testing of these promising ventures.

To date, their investment surpasses £25 million across a spectrum of projects, ranging from nascent-stage research to pioneering phase 2 clinical trials of innovative treatments.

Yet, their vision extends beyond current achievements. We are set to channel an additional £20 million by 2026, aiming to usher in groundbreaking treatments for Parkinson’s disease, transforming futures within years, not decades.

After Meeting Files